Bios Partners β Full Portfolio
10 tracked investments Β· listed companies and verified rows first
Clinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.
BiotechFort Worth, US
Daniel Schmitt(Executive Officer, Director)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Board seatAaron G.L. FletcherLeslie W. Kreis, Jr.Β· per SEC Form D
Co-investorsIllinois VenturesKairos Venture Investments, LlcBios
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Azim Munivar(Executive Officer, Director, Promoter)
Board seatStella RobertsonTravis WhitfillΒ· per SEC Form D Β· $4.5M raise Β· filed Oct 2022
Co-investorsKdT Ventures
Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases.
BiotechHealthtechMedical DevicesBoston, US
Daniel Baker(Executive Officer)Colin Sandercock(Executive Officer)Dominic Borie(Chief Medical Officer and Head of Research and Development)Sumita Ray(Executive Officer)Michael Meluzio(Executive Officer)Rodolfo Chaparro(Vice President, Head of Immunology)
Board seatAaron G.L. FletcherΒ· per SEC Form D Β· $30M raise Β· filed Nov 2022
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Board seatStella RobertsonΒ· per SEC Form D
Co-investorsExSight VenturesSolasta VenturesAccess BiotechnologyCorrelation VenturesFemHealth VenturesHatteras Venture Partners+2 more
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.
BiotechHealthtechMedical DevicesAnn Arbor, US
David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in
BoardAaron Fletcher(Director)in
Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesInFocus Capital Partners, LLCJohnson & Johnson Innovation β JJDC+3 more
410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.
HardwareHealthtechMedical DevicesDurham, US
Mark Donald Piehl(Executive Officer, Director)KYLE CHENET(Executive Officer, Director)
BoardJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FRED GOLDWATER(Director)inMAYANK TANEJA(Director)in
Board seatTravis WhitfillΒ· per SEC Form D Β· $4M raise Β· filed Aug 2018
Co-investorsBallad VenturesCU Healthcare Innovation FundDuke Capital PartnersOSF VenturesWolfpack Investor NetworkHatteras Venture Partners
BiotechHummelstown, US
Stephen C. Rocamboli(Executive Officer, Director)Rifat Pamukcu(Director)Robert Towarnicki(Executive Officer, Director)Roger Sawhney(Director)
BoardJohn Fucci(Director)in
Board seatTim Van TreurenΒ· per SEC Form D Β· $42.1M raise Β· filed Jan 2024
Co-investorsBioAdvanceLife Sciences Greenhouse Investments
BiotechAustin, US
James Brian Windsor(President and CEO)Steven Idell(Director)
BoardAaron Fletcher(Director)inJoseph Woelkers(Director)Robert Mills(Director)
Board seatAaron G.L. FletcherΒ· per SEC Form D Β· $15M raise Β· filed Apr 2022
Co-investorsUT Horizon Fund
Actuate provides AI video analytics that integrate with existing camera systems and video monitoring software to detect threats such as guns, intruders, crowds, unauthorized access, and fire while reducing false alarms.
AI & Machine LearningCloud ComputingCybersecurity
Sonny Tai(Founder)
Co-investorsBling CapitalDorm RoomGray Line PartnersMetaPropMetaProp VenturesScribble Ventures+3 more
Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems.
BiotechDeep TechHealthtechHouston, US
H. Davis Adkisson(Chief Scientific Officer)Chris Garabedian(Director)William Schwieterman(Board of Directors)Fred Callori(Director)
BoardAmanda De La Garza(Director)in
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.